CIK 0000885590
- Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- Operating
- Phone
- +1 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-14 | Pershing Square Capital Management, L.P. Director | Sale · Call Option (call equivalent position) | −91,200 | $0.30 | $27K | 0 |
| 2017-03-13 | Pershing Square Capital Management, L.P. Director | Sale | −18,114,432 | $11.00 | $199.3M | 0 |
| 2017-03-13 | Pershing Square Capital Management, L.P. Director | Purchase · Put Option (call equivalent position) | −9,120,000 | $47.65 | $434.6M | 0 |
| 2016-12-12 | Pershing Square Capital Management, L.P. Director | Sale | −3,476,690 | $14.85 | $51.6M | 18,114,432 |
| 2016-12-12 | Pershing Square Capital Management, L.P. Director | Purchase · Call Option (put equivalent position) | +9,120,000 | $0.01 | $91K | 0 |
| 2016-06-09 | Pershing Square Capital Management, L.P. Director | Purchase · Put Option (call equivalent position) | −9,120,000 | $35.80 | $326.5M | 0 |
| 2016-06-09 | Pershing Square Capital Management, L.P. Director | Sale · Call Option (call equivalent position) | −9,120,000 | $0.03 | $274K | 0 |
| 2016-06-09 | Pershing Square Capital Management, L.P. Director | Purchase · Call Option (call equivalent position) | +91,200 | $4.00 | $365K | 91,200 |
| 2016-06-09 | Pershing Square Capital Management, L.P. Director | Sale · Put Option (call equivalent position) | +9,120,000 | $37.09 | $338.3M | 9,120,000 |
Page 1 of 1 · 9 trades